Search research articles
Contact Us
Filters
Showing results (11-20 of 156) with videos related to
Page
of 16
Sort By:
American Journal of Therapeutics
|
September 9, 2005
Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model
Shashank Rohatagi, Sriram Krishnaswami, Marc Pfister, et al.
Pediatric Nephrology (Berlin, Germany)
|
March 2, 2021
Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD-a large observational study with follow-up to young adult age
Verena Gotta, Olivera Marsenic, Andrew Atkinson, et al.
Biologics in Therapy
|
August 15, 2014
Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency
Jagdev Sidhu, Mikhail Rojavin, Marc Pfister, et al.
Therapeutische Umschau. Revue Therapeutique
|
December 15, 2015
[Understanding and reducing the risk of adverse drug reactions in pediatric patients]
Verena Gotta, Johannes van den Anker, Marc Pfister
Expert Opinion on Drug Discovery
|
July 25, 2012
The current role of model-based drug development
Satyendra Suryawanshi, Liping Zhang, Marc Pfister, et al.
Journal of Clinical Pharmacology
|
July 6, 2023
Characterizing Associations of QTc Interval with Nocturnal Glycemic Control in Children with Type 1 Diabetes
Verena Gotta, Sara Bachmann, Marc Pfister, et al.
Journal of Clinical Pharmacology
|
January 11, 2012
Design, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney function
Michael A Tortorici, David Cutler, Lei Zhang, et al.
Journal of Clinical Pharmacology
|
September 10, 2008
Importance of characterizing determinants of variability in exposure: application to dasatinib in subjects with chronic myeloid leukemia
Guowei Dai, Marc Pfister, Anne Blackwood-Chirchir, et al.
Clinical and Translational Science
|
December 10, 2021
Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling
Daniela Hofmann, Cornelis Smit, Somphou Sayasone, et al.
The Pediatric Infectious Disease Journal
|
February 11, 2016
Therapeutic Drug Monitoring for Anti-infective Agents in Pediatrics: The Way Forward
Nicole Ritz, Julia Bielicki, Marc Pfister, et al.
Page
of 16
Search research articles
Search
Showing results (11-20 of 156) with videos related to
Sort By:
Page
of 16
American Journal of Therapeutics
|
September 9, 2005
Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model
Shashank Rohatagi, Sriram Krishnaswami, Marc Pfister, et al.
Pediatric Nephrology (Berlin, Germany)
|
March 2, 2021
Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD-a large observational study with follow-up to young adult age
Verena Gotta, Olivera Marsenic, Andrew Atkinson, et al.
Biologics in Therapy
|
August 15, 2014
Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency
Jagdev Sidhu, Mikhail Rojavin, Marc Pfister, et al.
Therapeutische Umschau. Revue Therapeutique
|
December 15, 2015
[Understanding and reducing the risk of adverse drug reactions in pediatric patients]
Verena Gotta, Johannes van den Anker, Marc Pfister
Expert Opinion on Drug Discovery
|
July 25, 2012
The current role of model-based drug development
Satyendra Suryawanshi, Liping Zhang, Marc Pfister, et al.
Journal of Clinical Pharmacology
|
July 6, 2023
Characterizing Associations of QTc Interval with Nocturnal Glycemic Control in Children with Type 1 Diabetes
Verena Gotta, Sara Bachmann, Marc Pfister, et al.
Journal of Clinical Pharmacology
|
January 11, 2012
Design, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney function
Michael A Tortorici, David Cutler, Lei Zhang, et al.
Journal of Clinical Pharmacology
|
September 10, 2008
Importance of characterizing determinants of variability in exposure: application to dasatinib in subjects with chronic myeloid leukemia
Guowei Dai, Marc Pfister, Anne Blackwood-Chirchir, et al.
Clinical and Translational Science
|
December 10, 2021
Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling
Daniela Hofmann, Cornelis Smit, Somphou Sayasone, et al.
The Pediatric Infectious Disease Journal
|
February 11, 2016
Therapeutic Drug Monitoring for Anti-infective Agents in Pediatrics: The Way Forward
Nicole Ritz, Julia Bielicki, Marc Pfister, et al.
Page
of 16